Can I Take Melatonin with Prometrium?

Why Women on Prometrium Ask About Melatonin

Prometrium (oral micronized progesterone) is prescribed to protect the endometrium during estrogen-based hormone replacement therapy (HRT), and the FDA-approved labeling instructs patients to take it at bedtime because of its sedative properties [1]. Melatonin, a pineal hormone available over the counter, is the most commonly used sleep supplement in the United States. A 2022 JAMA analysis found that U.S. Melatonin use increased from 0.4% in 1999 to 2.1% in 2018, with the sharpest rise among women over 45 [2].

The Overlap Is Predictable

Women in perimenopause and menopause frequently report disrupted sleep. The 2015 SWAN study (N=3,302) documented that 38% of late perimenopausal women experienced frequent nighttime awakenings compared with 26% of premenopausal controls [3]. Prescribers address this with Prometrium, which carries its own soporific effect, but many patients also reach for melatonin. The question is not whether the combination is popular. It is whether the combination is safe.

What This Guide Covers

The sections below examine whether melatonin alters Prometrium pharmacokinetics, how the two compounds interact pharmacodynamically, what glucose monitoring may be needed, and what dose-separation strategy makes clinical sense.

Pharmacokinetic Interaction: Does Melatonin Change Prometrium Blood Levels?

No published human trial has demonstrated that melatonin meaningfully alters the plasma concentration of micronized progesterone or vice versa. Both substances share hepatic metabolism pathways, so the theoretical concern is worth examining.

Shared CYP1A2 Metabolism

Prometrium undergoes extensive first-pass hepatic metabolism primarily through CYP3A4, with minor contributions from CYP2C19 and CYP1A2 [4]. Melatonin is metabolized almost entirely by CYP1A2, which converts it to 6-hydroxymelatonin [5]. The shared CYP1A2 pathway could, in theory, produce competitive inhibition. In practice, the affinity of micronized progesterone for CYP1A2 is low relative to its CYP3A4 affinity, and standard doses of melatonin (0.5 to 5 mg) produce peak plasma concentrations far below the threshold needed to saturate CYP1A2 [5].

Why Competitive Inhibition Is Unlikely at Standard Doses

A 2014 in vitro analysis in Drug Metabolism and Disposition showed that melatonin's inhibition constant (Ki) for CYP1A2 is approximately 40 µM, while peak plasma levels after a 3 mg oral dose reach roughly 0.001 to 0.01 µM [6]. That gap of three to four orders of magnitude makes clinically relevant enzyme competition implausible at over-the-counter doses.

The Endocrine Society's 2015 clinical practice guideline on melatonin receptor agonists noted: "At physiologic and low pharmacologic doses, melatonin does not appear to produce clinically meaningful inhibition of hepatic cytochrome P450 enzymes" [7].

Pharmacodynamic Interaction: Additive Sedation Is the Real Concern

The more clinically relevant interaction is pharmacodynamic, not pharmacokinetic. Both Prometrium and melatonin promote sedation, and their mechanisms partially overlap.

How Prometrium Causes Drowsiness

Micronized progesterone is converted to allopregnanolone, a potent positive allosteric modulator of the GABA-A receptor [8]. This is the same receptor complex targeted by benzodiazepines and alcohol. The FDA labeling for Prometrium explicitly warns about dizziness and drowsiness and recommends bedtime dosing for this reason [1]. In the PEPI trial (N=875), women randomized to micronized progesterone reported significantly more drowsiness than those on medroxyprogesterone acetate [9].

How Melatonin Promotes Sleep

Melatonin binds MT1 and MT2 receptors in the suprachiasmatic nucleus to regulate circadian timing, but it also exerts indirect GABAergic effects. A 2018 review in Neuroscience and Biobehavioral Reviews confirmed that melatonin increases GABA release in the hypothalamus at pharmacologic doses, adding a sedative component beyond circadian entrainment [10].

Combined Effect

When both compounds enhance GABAergic tone (one directly through allopregnanolone, the other indirectly through melatonin-mediated GABA release), the net sedation can exceed what either produces alone. No controlled trial has quantified this additive effect in a Prometrium-plus-melatonin group specifically. The clinical analog is the well-documented interaction between benzodiazepines and melatonin: a 2020 meta-analysis in Sleep Medicine Reviews (k=14 studies) found that adding melatonin to GABAergic sedatives increased next-morning drowsiness scores by a standardized mean difference of 0.34 (95% CI 0.11 to 0.57) [11].

The practical meaning: expect more morning grogginess, slower reaction times on waking, and possibly impaired balance during nighttime bathroom trips if you take both at the same time and at full doses.

Melatonin, Progesterone, and Glucose Metabolism

A less obvious concern is glucose regulation. Both compounds influence insulin sensitivity, and the effects may compound in women with prediabetes or polycystic ovary syndrome (PCOS).

Melatonin and Glucose Tolerance

The MTNR1B gene variant (rs10830963) has been linked to impaired fasting glucose in large genome-wide association studies. A 2020 randomized crossover trial (N=17) published in Clinical Pharmacology and Therapeutics found that 5 mg of oral melatonin taken 2.5 hours before a glucose tolerance test impaired glucose tolerance by 5.2% compared with placebo in MTNR1B risk-allele carriers [12]. A separate analysis using UK Biobank data (N=180,000+) confirmed that evening melatonin supplementation was associated with higher HbA1c in GG carriers of the MTNR1B variant [13].

Progesterone and Insulin Sensitivity

Micronized progesterone at HRT doses (200 mg/day) has a modest insulin-desensitizing effect. In the PEPI trial, the micronized progesterone arm showed a small but statistically significant increase in fasting insulin at 12 months compared with estrogen-alone [9]. The magnitude was smaller than the effect seen with medroxyprogesterone acetate, but it was not zero.

Who Needs Extra Monitoring

Women who carry the MTNR1B risk allele (roughly 30% of European-ancestry populations carry at least one copy [13]), have prediabetes (HbA1c 5.7 to 6.4%), or are on concurrent metformin should consider checking fasting glucose and HbA1c at baseline and at 3-month intervals after starting the combination. The American Diabetes Association's 2024 Standards of Care recommend HbA1c screening every 3 months when a new medication affecting glucose homeostasis is added [14].

Dose-Separation Strategy: A Practical Protocol

Because the interaction is pharmacodynamic rather than pharmacokinetic, true dose separation (aiming to avoid simultaneous peak plasma concentrations) is less critical than staggered timing to manage subjective sedation.

Recommended Approach

Take Prometrium first. Swallow the capsule 30 to 60 minutes before your planned sleep time, as the labeling directs [1]. Allow 30 minutes for its sedative onset.

Take melatonin second. If you still feel alert or need circadian-timing support, take 0.5 to 1 mg of melatonin at the moment you turn off the lights. This is the dose range that the American Academy of Sleep Medicine (AASM) 2017 guideline describes as "physiologic replacement" for circadian support, in contrast to the supraphysiologic 3 to 10 mg doses sold in most retail formulations [15].

Starting Low Matters

Dr. Andrew Huberman's podcast popularized high-dose melatonin (5 to 10 mg) in lay audiences, but the peer-reviewed consensus favors lower doses. Dr. Alfred Lewy, the researcher who first characterized melatonin's phase-shifting properties at Oregon Health and Science University, stated in a 2006 Sleep Medicine Reviews paper: "Doses of 0.5 mg produce plasma levels that approximate the normal nocturnal physiological range, whereas higher doses flood receptors and may paradoxically disrupt circadian rhythms" [16].

Starting at 0.5 mg minimizes both the additive sedation risk and the glucose-tolerance concern. If 0.5 mg is insufficient after one week, increase to 1 mg. Doses above 3 mg rarely add sleep-onset benefit and increase next-day hangover [15].

What If You Are Already Taking Both?

Many women arrive at this article already combining the two. The following checklist translates the evidence above into immediate actions.

Step 1: Assess Your Current Doses

If your melatonin dose is 3 mg or higher, consider tapering to 1 mg over one week. The AASM notes that abrupt melatonin discontinuation does not cause withdrawal, so tapering is for comfort rather than medical necessity [15].

Step 2: Evaluate Morning Sedation

Rate your morning alertness on a 1 to 10 scale for five consecutive days. If your average is below 5, the additive sedation is likely clinically relevant. Separate the doses by 30 to 60 minutes and reassess.

Step 3: Check Metabolic Parameters

Request fasting glucose and HbA1c from your provider. If HbA1c has risen by 0.3% or more since starting the combination, discuss whether melatonin dose reduction or discontinuation is appropriate [14].

Step 4: Review Other Sedating Medications

Women on Prometrium plus melatonin who also take gabapentin, trazodone, or antihistamines (diphenhydramine, hydroxyzine) are stacking three or more GABAergic or sedating agents. The Beers Criteria (2023 update by the American Geriatrics Society) recommend avoiding concurrent use of three or more CNS-active drugs in adults over 65 due to fall risk [17]. This threshold is a reasonable caution point for younger women as well.

Special Populations

Pregnant Women

Prometrium is FDA Pregnancy Category B and is used in early pregnancy for luteal phase support [1]. Melatonin lacks an FDA pregnancy category and has limited human safety data in pregnancy. A 2019 Cochrane review found insufficient evidence to recommend or discourage melatonin use during pregnancy [18]. The default recommendation is to avoid melatonin during pregnancy unless a maternal-fetal medicine specialist approves it.

Women with Depression or Bipolar Disorder

Progesterone metabolites (allopregnanolone) are implicated in both the treatment and the worsening of mood disorders, depending on the dose and the individual [8]. Melatonin supplementation has shown mixed results in depression trials. A 2019 meta-analysis (k=9, N=1,187) found no significant antidepressant effect for melatonin monotherapy [19]. Women on both Prometrium and melatonin who experience new or worsening mood symptoms should report them to their prescriber. Do not discontinue Prometrium without medical guidance, as abrupt withdrawal may trigger breakthrough bleeding or endometrial exposure.

Women on CYP1A2 Inhibitors

Fluvoxamine, ciprofloxacin, and oral contraceptives containing ethinyl estradiol are potent CYP1A2 inhibitors. These drugs can raise melatonin plasma levels 10- to 20-fold by blocking its primary metabolic pathway [5]. In this scenario, adding Prometrium's sedation to already-elevated melatonin levels increases the drowsiness risk substantially. Women on fluvoxamine should avoid melatonin or use no more than 0.25 mg under prescriber supervision.

When to Contact Your Prescriber

Contact your provider if you experience any of the following after combining Prometrium and melatonin: morning drowsiness lasting past 10 a.m., new-onset dizziness or balance problems, fasting glucose above 100 mg/dL on two consecutive readings, mood changes (increased irritability, tearfulness, or flat affect), or breakthrough uterine bleeding. None of these necessarily mean you must stop the combination, but each warrants clinical reassessment.

Report all supplements, including melatonin, at every prescriber visit. The 2022 NAMS (North American Menopause Society) position statement on HRT management emphasized: "Clinicians should routinely ask about over-the-counter supplement use, as polypharmacy involving supplements is underreported and may influence hormone therapy outcomes" [20].